002294 Shenzhen Salubris Pharmaceuticals Co., Ltd. SZSE · China

Shenzhen Salubris Pharmaceuticals Co. (002294) news

Shenzhen Salubris Pharmaceuticals Co., Ltd. is a public biotech or pharmaceutical company listed on SZSE under the ticker 002294, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Shenzhen Salubris Pharmaceuticals Co. news

We have not published a story on Shenzhen Salubris Pharmaceuticals Co. yet. When there is news, it will appear here.

Questions about Shenzhen Salubris Pharmaceuticals Co.

What is the ticker symbol of Shenzhen Salubris Pharmaceuticals Co.?

Shenzhen Salubris Pharmaceuticals Co., Ltd. trades under the ticker 002294 on SZSE.

Where is Shenzhen Salubris Pharmaceuticals Co. listed?

Shenzhen Salubris Pharmaceuticals Co., Ltd. is listed on SZSE.

Which country or territory is Shenzhen Salubris Pharmaceuticals Co. listed under?

Our directory records Shenzhen Salubris Pharmaceuticals Co., Ltd. under China.

What does Shenzhen Salubris Pharmaceuticals Co. do?

Our directory classifies Shenzhen Salubris Pharmaceuticals Co., Ltd. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of Shenzhen Salubris Pharmaceuticals Co.?

The ISIN recorded for Shenzhen Salubris Pharmaceuticals Co., Ltd. is CNE100000FW8.

Does aibio.space cover Shenzhen Salubris Pharmaceuticals Co.?

aibio.space lists Shenzhen Salubris Pharmaceuticals Co., Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Shenzhen Salubris Pharmaceuticals Co.?

Companies in our directory listed in the same country and business area as Shenzhen Salubris Pharmaceuticals Co.: Jenkem Technology Co., Hua Medicine, China National Medicines Corporation, ImmuneOnco Biopharmaceuticals (Shanghai), Hunan Warrant Pharmaceutical Co., Harbin Pharmaceutical Group Co..

Investor discussion: Shenzhen Salubris Pharmaceuticals Co.

Members talk about Shenzhen Salubris Pharmaceuticals Co. (002294). Reader posts, not aibio.space reporting, and not investment advice.

Rules

Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
Say whether you hold the stock. Every post states long, short or no position.
No paid or sponsored posts. Do not post for anyone who pays or rewards you.
No buy or sell calls and no price targets.
No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open SZSE:002294 on TradingView.

Listing details

Company: Shenzhen Salubris Pharmaceuticals Co., Ltd.
Ticker: 002294
Listing: SZSE
Country or territory: China
Business scope: Pharmaceuticals: Major
ISIN: CNE100000FW8
Last quote in directory: 2026-10-22
Directory source: Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction